$IBB at channel resistance with negative divergenceLook for further weakness and pullback following rejection at the channel with negative RSI divergenceShortby kevin1533116
IBBSystem T Performances: Annual Compound Profit 40%, Win Rate 55%, Risk/Reward Ratio 1:2, 20 Years of Backtesting Data, Over 100 Markets. * Click Like and Follow to Support My Work! --- Hi Traders, I'd like to introduce the System T, a computerized trading system that analyzed and backtested the 20 years history data of over 100 markets. This post is my sharing of how I think about systematic trading and the signals generated by the System T. (This is my opinion only, NOT the financial advice.) The System T is a comprehensive system which contains many components such as buy & sell signal generator, win & loss statistics, risk control & portfolio management to make sure trading is successful in the long run. Basically, for the system to open a trade and manage risk, it only needs a buy signal & a stop-loss signal clearly on the chart. Once the system finds a good trend, it will ride it as long as possible. The stop-loss will be adjusted accordingly to the new price movement. (*) Remember to follow this trade idea and follow my profile to get updates about the stop-loss adjustment and sell signal based on the latest price and market conditions daily. System T performances above will give you an idea of how it performs in the last 20 years. Notice that this result was achieved only if I strictly followed the rule: "Only and Always Buy & Sell based on the System Signals". Don't sell when there is no sell signal as we all want to follow the good trends til the end like everything in life does. \(^-^)/ Also, my system is extremely diversified through over 100 markets so that it only risks less than -1% of the total capital per trade. Thank you and good luck! --- DISCLAIMER: I am NOT a financial advisor, and nothing I say is meant to be a recommendation to buy or sell any financial instrument. My views are general in nature and I am not giving financial advice. You should not take my opinion as financial advice. This is my opinion only. Do your own due diligence, and take 100% responsibility for your financial decisions. Trading and investing are risky! Don't invest money you can't afford to lose, because many traders and investors lose money. There are no guarantees or certainties in trading. - Content is for education purposes only, not investment advice. - Trading involves a high degree of risk. - We’re not investment or trading advisers. - Nothing we say is a recommendation to buy or sell anything. - There are no guarantees or certainties in trading. - Many traders lose money. Don’t trade with money you can’t afford to lose. by System_TUpdated 6
$IBB Looking Near Term Over-extended$IBB Looking Near Term Over-extended Long term rising wedge has formed. If broken, we could see $124.00 in medium term. Note: Not investment advice.Shortby Triple_Barrel_Capital117
Big Biotechs Ascending TriangleIBB is forming an ascending triangle, which is a continuation pattern after the breakout. Important to note the 20sma, which has been very supportive in the trend. The is also some support we can see many candlesticks with bottom wicks, meaning the shorts were met with buyers very quickly. by dorfmanmaster1
Biotech continues to grind higherLord knows many of the companies in this ETF are probably shite but $IBB continues to show strength. For now - long biotech !Longby dotpem2
Biotech is where the cool kids are doing!What I see... + Prices pulled back from $136 to find support from the rising 10ma + Friday's bar painted a bullish engulf-like body within a NR7 on very low volume! This is like a spring that is compressed and getting ready to bounce! + RSI is at 61 and has just turned upward + MACD is flat in the bullish zone - MACD is technically below signal line - $136 is first resistance What I setup... + Long entry above Friday's high - Stop under last week's low + Target at 1.618Fib :: Duration - weeks! ** Comments and Likes are appreciated; New Subscribers are stronger than biotech! **Longby ShakeShakeLegUpdated 3
IBB is at all time highs and goes much higherOn a long term basis Biotech is finally coming into a new bullish phase. IBB is above 133 and is going much higher.Longby adxcl5
$IBB #IMFTchart Bullish wedge formingBullish wedge forming. After yesterdays huge Biotech moves, I would expect to see a continued downtrend until end of wedge. Longby IMF_Trading5
IBB - reached forecasted target and should correctIBB reached the target we forecasted on May 6 and at this stage it should have completed primary wave 5. It should now start a correction that can take it to new lows. The alternative scenario would be that we would see a minor correction to around 115 before trend to new highs. However, in both cases prices should follow the path to at least arounf the most probable target of 115. If prices crosses up 136 this analysis should be reviewed. FOLLOW SKYLINEPRO TO GET UPDATES.Shortby SkylineProUpdated 3
IBB - Biotech ETF could offer good potentialIBB seems to have starting minor wave 5 up that could lead its price to the most probable target of 134.00. This sector should be be one of the good options to be in during the current market scenario. If prices crosses down 199.70, this analysis should be reviewed. FOLLOW SKYLINEPRO TO GET UPDATES.Longby SkylineProUpdated 6
IBB breakout comingIBB is ready to revisit the highs of 133 made in July 2015, after a 4x increase since 2011 which was the equivalent of the dot-com bubble. Assuming that pandemic issues are going to be a recurring catalyst, biotech could be ready to take again the mantle of market leader from technology (maybe it is a relay?). Anyway, it seems a cup-and-handle breakout from 130s is ready to go (supported by increased volume, and the fact the ATR is back to its highs). Longby nikodemuskell2
IBB 2W best level to BUY 50% gains (STOCKS/NEW)before we kick start the update. your upvotes/subs are appreciated. Why get subbed to to me on Tradingview? -TOP author on TradingView -professional chart break downs -key levels -no junk on my charts -frequent updates -covering FX/crypto/US stocks -24/7 uptime so constant updates So without further due. Keep it short/simple and to the point. IBB 2W best level to BUY 50% gains IMPORTANT NOTE: tagged as SHORT cause I expect more short-term losses. under long-term accumulation on 2w chart. Biotechs are a lot better positioned for recovery after coronavirus starts to fade. Biotechs in spotlight, and I expect IBB to outperform SPY going forward next few years (aging population,etc). recommended strategy: accumulate later near range lows 82//86. TP 120//140 +50 get subbed to stay tuned for all the latest updates. also add likes to support my efforts, thank you. good luck traders. Shortby ProjectSyndicate11110
IBB Alerts set above the boxLike IBB if it breaks and holds the box on chart. Targets at extensions. Stops below box.Longby WadeYendallUpdated 8
IBB: The time is now...tight risk, huge reward potentialI think @timwest's idea that #TSLA and #IBB both represent innovation and disruption, and so, #IBB should correlate #TSLA (which has been the case so far), gives us a good opportunity as a less evident catch up play, to follow #TSLA's violent climb. Perhaps some company in the portfolio manages to find a vaccine that resolves the Coronavirus crisis, as a possible catalyst to boost the ETF higher. The technical chart is absolutely perfect now, we have a daily and weekly explosion pattern setup, where most of the recent highs align near the same zone, and price breaking out above them. I will add some more detail as updates, lower timeframe and higher timeframe charts, as well as other interesting tidbits supporting this idea. For full disclosure: I'm long #IBB and #BTC currently, sold #TSLA for now, not in a rush to buy it back. My clients receive timely updates to benefit from my derivatives trading and my position shifts in my stock, crypto and FX portfolios. If interested in being part of this community, message me for more details. Cheers, Ivan Labrie.Longby IvanLabrieUpdated 1118
IBB - Biotech BounceWhats up Traders - Stealing a CNBC idea, but i like it and agree with it. Biotech has bounced back to its past highs. IN all liklihood we will bounce around here for a bit - Entering a Call Credit Spread 1 x 123.5 Call Sell Jan 31 1 x 125.00 Call Buy Jan 31 Have a look and see if you. Best of luck. - NixShortby WillNixTradingUpdated 7
IPO: BDTXjust a new Idea. See the text on the chart. Buying on first-second day still might be a good option.by KholleKhokkUpdated 9